JAMA Otolaryngology-Head & Neck Surgery

Papers
(The H4-Index of JAMA Otolaryngology-Head & Neck Surgery is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Well-Demarcated Nasopharyngeal Mass in an Adolescent Male105
Proton Therapy and Incidence and Predisposing Factors of Osteoradionecrosis—On Pulling One’s Punches95
Dental Extractions Before Radiation Therapy and the Risk of Osteoradionecrosis in Patients With Head and Neck Cancer79
Association of Core Biopsy With Extranodal Extension in Surgically Treated Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma70
Risk of Carcinoma in Pleomorphic Adenomas of the Parotid67
Congenital Cholesteatoma Revealed by Recurrent Neck Cellulitis in Patient With Otomandibular Syndrome63
A Novel Case of Clofazimine-Induced Purple Nasal Mucosal Discoloration63
Necrotizing Sialometaplasia in a Medically Compromised Patient—A Potential Diagnostic Pitfall63
Bilateral Linear Oral Ulcerations and Facial Swelling in a Young Woman58
Error in Affiliations53
Sentinel Node Biopsy in Oral Cancer—Indications, Analysis, and Outcomes—Reply47
A Child With Recurrent Jaw Swelling47
First-in-Human Hyperpolarized MRI for Tumor Metabolism in HNSCC45
Tongue Metastasis From Pleural Mesothelioma45
A Rare Case of Laryngeal Mantle Cell Lymphoma44
Quality Indicators for the Diagnosis and Management of Primary Hyperparathyroidism43
Olfactory and Gustatory Function 3 Years After Mild COVID-19—A Cohort Psychophysical Study42
Enhanced Recovery After Surgery Compliance and Outcomes for Head and Neck Reconstructive Surgery42
JAMA Otolaryngology–Head & Neck Surgery40
JAMA Otolaryngology–Head & Neck Surgery39
Size Threshold Surveillance—A Revised Approach to Wait-and-Scan for Vestibular Schwannoma39
Tumor Histological Grade and Immunotherapy Response in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma39
Gene Therapy for Hearing Loss—Will the Price be Right?38
Assessment of Sleep Features, Mental Health Outcomes, and Alcohol and Tobacco Consumption in Residents and Fellows in Otolaryngology Before and During the COVID-19 Pandemic37
Underreporting and Underrepresentation of Race and Ethnicity in Head and Neck Cancer Trials, 2010-202036
Comorbid Depression in Patients With Head and Neck Cancer Compared With Other Cancers36
Mouth Closure and Airflow in Patients With Obstructive Sleep Apnea35
Effect of Physician Consultation on Satisfaction With Hearing Aid Use35
Are We Undertreating Pain—A Review of the CDC 2022 Opioid Prescription Guidelines in the Context of Otolaryngology34
Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer34
JAMA Otolaryngology–Head & Neck Surgery34
A Hump-like Neck Mass in a Child33
JAMA Otolaryngology–Head & Neck Surgery32
0.10941314697266